ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 324979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 324979; 2) Community: the network communities that were significantly associated with the response to NSC 324979; 3) Molecule: the relationships between components within communities and NSC 324979; 4) MDR: the compounds that were significantly associated with the NSC 324979.

NSC Compound Enrichment Correlation
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00356914129105571 0.44228092
NSC 310547 Null 0.00356914129105573 0.57229726
NSC 681646 Camptothecin Derivative 0.00356914129105577 0.18884854
NSC 155594 Null 0.00385572727186 0.30548415
NSC 382053 Null 0.00385572727186009 0.49984912
NSC 628301 Null 0.00385572727186009 0.38880751
NSC 654376 ANTINEOPLASTIC-654376 0.00385572727186009 0.68449575
NSC 664403 Null 0.00385572727186009 0.41563163
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.00385572727186009 0.27040946
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.00385572727186009 0.52655286
Total:104  Current:20    [First] [Prev] [Next] [Last]